Investigation Report on China's Dexmedetomidine Market 2021-2025

SKU ID : CRI- 18501082

Publishing Date : 08-Jun-2021

No. of pages : 50


  • Dexmedetomidine is a highly selective α2-adrenergic receptor agonist. It is mainly used clinically for the sedation of tracheal intubation and mechanical ventilation in surgical patients undergoing general anesthesia. It was developed by Abbott and Orion Corp. According to CRI’s market research, as of the end of 2020, the original drug of Dexmedetomidine has not been listed in China. In 2009, Jiangsu Hengrui Medicine Co., Ltd. first imitated the drug and was approved to be listed in China. By 2020, there are 5 manufactures in Chinese Dexmedetomidine market, of which Yangtze River Pharmaceutical is the main manufacture.

    According to CRI’s market research, the sales value of Dexmedetomidine in the Chinese market increased year by year at a steady growth rate from 2016 to 2019. Especially, affected by the "4+7" centralized procurement by the Chinese government in 2018, its sales volume increased by 29.66% year-on-year, and sales increased by nearly 18% year-on-year. Due to the impact of COVID-19 on the overall diagnosis and treatment services of Chinese hospitals, the sales value of Dexmedetomidine in the Chinese market decreased to CNY 984 million in 2020, a year-on-year decrease of 3.45%. The CAGR of sales value of Dexmedetomidine in the Chinese market is 11.8% in 2016 to 2020, which is a very high level.

    CRI expects that the sales of Dexmedetomidine in the Chinese market will have a restorative growth from 2016 to 2020 as the alleviation of the COVID-19 epidemic. In addition, as a new type of α2 adrenergic receptor agonist, Dexmedetomidine has significant advantages such as high selectivity, strong sedative and analgesic effects, anti-anxiety and hemodynamic stability. Based on these advantages, the sales value and sales volume of Dexmedetomidine still have room to rise.

    Topics Covered:
    -The impact of COVID-19 on China's Dexmedetomidine market
    - Sales value of China's Dexmedetomidine 2016-2020
    - Competitive landscape of China's Dexmedetomidine market
    - Prices of Dexmedetomidine in China
    - Prices of Dexmedetomidine in China by regions and manufacturers
    - Analysis on factors affecting the development of China's Dexmedetomidine market
    - Prospect of China's Dexmedetomidine market from 2021 to 2025

    Frequently Asked Questions

    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports